Clinical Trials for Lytix Biopharma

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Lytix Biopharma

Clinical Trials (1)

NCT06651151
NeoLIPA: Neoadjuvant LTX-315 in Combination with Pembrolizumab in Resectable Stage III/IV Melanoma
PHASE2Recruiting
27 participants
Started: Nov 1, 2024 · Completed: May 31, 2031
1 condition2 sponsors1 location